Influence of Extended Photoperiod Using Blue Light Masks on Hypertrichosis, Coat Condition and General Health Parameters in Horses with Pituitary Pars Intermedia Dysfunction.
Abstract: Fifty-two horses aged >15 years, diagnosed with pituitary pars intermedia dysfunction (PPID), and displaying hypertrichosis were recruited via an online survey of PPID horse owners. From mid-December, group T ( = 29) wore Equilume light masks extending photoperiod to 15 h daily, while group C1 ( = 23) remained under natural photoperiod. As 85% (44/52) of recruited study horses received pergolide medication, a second unmedicated PPID research herd (C2; = 17) was recruited and remained under natural photoperiod. Hair coat samples, shedding and body condition scores were collected monthly by owners for 13 months and analysed by the research team. Data related to management, coat condition and PPID clinical signs were collected using bimonthly questionnaires (BMQ). Time ( < 0.001), group ( = 0.025) and time-by-group interaction ( = 0.005) affected hair length. Group differences were attributable to shorter hair lengths in C2, and no differences in hair length occurred between T and C1 ( > 0.05). Time affected shedding scores ( < 0.001) which was advanced by one month in T ( < 0.05). In group T, BMQ responses showed improved coat condition in April ( = 0.035), decreased fat coverage in April and June ( < 0.05), and increased energy/alertness in February ( = 0.022). Improvements in coat condition ( = 0.043), clinical signs of PPID ( = 0.018), and general quality of life ( = 0.035) were reported in T only in a final study questionnaire. Blue light treatment merits further investigation as a complementary treatment for PPID.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
Overview
This study investigated the effects of extending daily light exposure using blue light masks on horses with pituitary pars intermedia dysfunction (PPID), focusing on hair growth, coat condition, and overall health.
Researchers compared horses receiving blue light therapy to those under natural light conditions, examining hair length, shedding, body condition, and clinical symptoms over 13 months.
Background
PPID, also known as equine Cushing’s disease, is a common hormonal disorder in older horses, typically those older than 15 years.
The condition often leads to hypertrichosis, which is excessive hair growth, poor coat condition, and other general health issues.
Management of PPID usually involves medication such as pergolide, but complementary treatments that might improve symptoms are of interest.
Photoperiod, or the length of daily light exposure, has been shown to influence hair growth and shedding cycles in horses.
Blue light masks are a novel approach to artificially extend the photoperiod, potentially improving endocrine-related symptoms.
Study Design
Participants: 52 horses diagnosed with PPID, exhibiting hypertrichosis, mostly aged over 15 years.
Grouping:
Group T (n=29): Wore Equilume blue light masks to extend photoperiod to 15 hours daily from mid-December.
Group C1 (n=23): Control group under natural photoperiod, most receiving standard pergolide medication.
Group C2 (n=17): Unmedicated PPID horses, serving as a second control group under natural photoperiod to account for medication effects.
Data Collection:
Monthly hair coat samples, shedding assessments, and body condition scoring conducted by horse owners for 13 months.
Bimonthly questionnaires to collect data on management, coat condition, and PPID clinical signs.
Key Findings
Hair Length:
Time (seasonal changes), group membership, and their interaction influenced hair length significantly.
Group C2 (unmedicated controls) had shorter hair compared to other groups, indicating natural shedding or better condition without medication.
No significant difference in hair length between the blue light treatment group (T) and medicated control group (C1) was found.
Shedding Scores:
Shedding progressed over time for all groups, but in the blue light group (T), shedding occurred one month earlier, suggesting that extended light exposure may accelerate the shedding cycle.
Body Condition and Energy:
Owners reported improved coat condition in the blue light group (T) in April.
Decreased fat coverage scores, possibly indicating healthier body condition, were noted in April and June in group T.
Increased energy and alertness were also reported for the blue light group in February.
Overall Health and Clinical Signs:
Only horses in the blue light treatment group reported improvements in coat condition, clinical signs of PPID, and general quality of life by study end.
These improvements suggest potential therapeutic benefits from extending photoperiod using blue light masks beyond medication alone.
Conclusions and Implications
Blue light masks that extend daily light exposure show promise as a complementary treatment for horses with PPID.
The intervention may help advance natural hair shedding cycles and improve coat quality and general health status.
While blue light treatment did not reduce hair length compared to medicated controls, it positively impacted other clinical signs and subjective health parameters.
Further research is recommended to confirm these findings, optimize treatment protocols, and understand mechanisms.
This approach could represent a non-pharmacological adjunct therapy, potentially improving quality of life in affected horses.
Cite This Article
APA
Parmantier S, Kyriazopoulou P, McClendon M, Adams A, Murphy BA.
(2025).
Influence of Extended Photoperiod Using Blue Light Masks on Hypertrichosis, Coat Condition and General Health Parameters in Horses with Pituitary Pars Intermedia Dysfunction.
Animals (Basel), 15(19), 2905.
https://doi.org/10.3390/ani15192905
School of Agriculture and Food Science, University College Dublin, Belfield, Dublin 4, Ireland.
Kyriazopoulou, Panoraia
Equilume Ltd., Ladytown Business Park, Naas, W91 TP22 Co. Kildare, Ireland.
McClendon, Margaret
M.H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY 40546, USA.
Adams, Amanda
M.H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY 40546, USA.
Murphy, Barbara A
School of Agriculture and Food Science, University College Dublin, Belfield, Dublin 4, Ireland.
Grant Funding
n/a / Equilume (Ireland)
n/a / University College Dublin
n/a / University of Kentucky
Conflict of Interest Statement
B.A.M is a cofounder of Equilume Ltd., a spin-out company deriving from her research as associate professor at University College Dublin and is a member of the company’s board of directors. P.K. was an employee of Equilume Ltd. in the role of research manager at the time of the study.
Scott DW, Miller WH. Equine Dermatology.. Elsevier; Amsterdam, The Netherlands: 2003. Endocrine, Nutritional, and Miscellaneous Haircoat Disorders; pp. 548–570.
Glover CM, Miller LM, Dybdal NO, Lopez A, Duckett WM, McFarlane D. Extrapituitary and Pituitary Pathological Findings in Horses with Pituitary Pars Intermedia Dysfunction: A Retrospective Study.. J. Equine Vet. Sci. 2009;29:146–153.
Gebbie FE, Forsyth IA, Arendt J. Effects of Maintaining Solstice Light and Temperature on Reproductive Activity, Coat Growth, Plasma Prolactin and Melatonin in Goats.. Reproduction. 1999;116:25–33.
Guerin MV, Wang XJ. Environmental Temperature Has an Influence on Timing of the First Ovulation of Seasonal Estrus in the Mare. Theriogenology 1994;42:1053–1060.
Schmidt K, Deichsel K, De Oliveira RA, Aurich J, Ille N, Aurich C. Effects of Environmental Temperature and Season on Hair Coat Characteristics, Physiologic and Reproductive Parameters in Shetland Pony Stallions. Theriogenology 2017;97:170–178.
Geyfman M, Plikus MV, Treffeisen E, Andersen B, Paus R. Resting No More: Re-defining Telogen, the Maintenance Stage of the Hair Growth Cycle. Biol. Rev. 2015;90:1179–1196.
Brainard GC, Sliney D, Hanifin JP, Glickman G, Byrne B, Greeson JM, Jasser S, Gerner E, Rollag MD. Sensitivity of the Human Circadian System to Short-Wavelength (420-Nm) Light. J. Biol. Rhythm. 2008;23:379–386.
Chu Y, Shieh K, Yuan ZF, Pan J. Stimulatory and Entraining Effect of Melatonin on Tuberoinfundibular Dopaminergic Neuron Activity and Inhibition on Prolactin Secretion. J. Pineal Res. 2000;28:219–226.
Li H, Wei J, Ma F, Shan Q, Gao D, Jin Y, Sun P. Melatonin Modulates Lactation by Regulating Prolactin Secretion Via Tuberoinfundibular Dopaminergic Neurons in the Hypothalamus- Pituitary System. Chronic Pelvic Pain Syndr. 2020;21:744–750.
Grymowicz M, Rudnicka E, Podfigurna A, Napierala P, Smolarczyk R, Smolarczyk K, Meczekalski B. Hormonal Effects on Hair Follicles. Int. J. Mol. Sci. 2020;21:5342.
Rendle DI, Taylor E, Duz M, Parkin TD, Copas VEN, Durham AE. Effects of Pergolide Mesylate on Plasma Adrenocorticotropic Hormone Concentration in Horses with Pituitary Pars Intermedia Dysfunction. Equine Vet. J. 2013;45:19.
Gehlen H, May A, Bradaric Z. Comparison of Insulin and Glucose Metabolism in Horses with Pituitary Pars Intermedia Dysfunction Treated Versus Not Treated with Pergolide. J. Equine Vet. Sci. 2014;34:508–513.
Killgore WDS, Dailey NS, Raikes AC, Vanuk JR, Taylor E, Alkozei A. Blue Light Exposure Enhances Neural Efficiency of the Task Positive Network during a Cognitive Interference Task. Neurosci. Lett. 2020;735:135242.
Poole J, Kitchen GB. Circadian Regulation of Innate Immunity in Animals and Humans and Implications for Human Disease. Semin. Immunopathol. 2022;44:183–192.
Parmantier S, Kyriazopoulou P, McClendon M, Adams A, Murphy BA. Influence of Extended Photoperiod Using Blue Light Masks on Hypertrichosis, Coat Condition, and General Health Parameters in Horses with Pituitary Pars Intermedia Dysfunction. J. Equine Vet. Sci. 2025;148:105534.
Cajochen C, Münch M, Kobialka S, Kräuchi K, Steiner R, Oelhafen P, Orgül S, Wirz-Justice A. High Sensitivity of Human Melatonin, Alertness, Thermoregulation, and Heart Rate to Short Wavelength Light. J. Clin. Endocrinol. Metab. 2005;90:1311–1316.
Videnovic A, Klerman EB, Wang W, Marconi A, Kuhta T, Zee PC. Timed Light Therapy for Sleep and Daytime Sleepiness Associated with Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol. 2017;74:411.
Charkhabi SA, Sharifi Z, Janizadeh R, Rahdar M, Kazemi R. The Effect of Blue Light on Cognitive Function at Workplaces: A Systematic Review. Physiol. Behav. 2025;289:114758.
Itzhacki J, Clesse D, Goumon Y, Van Someren EJ, Mendoza J. Light Rescues Circadian Behavior and Brain Dopamine Abnormalities in Diurnal Rodents Exposed to a Winter-like Photoperiod. Brain Struct. Funct. 2018;223:2641–2652.
Yamazaki S, Numano R, Abe M, Hida A, Takahashi R, Ueda M, Block GD, Sakaki Y, Menaker M, Tei H. Resetting Central and Peripheral Circadian Oscillators in Transgenic Rats. Science 2000;288:682–685.
West KE, Jablonski MR, Warfield B, Cecil KS, James M, Ayers MA, Maida J, Bowen C, Sliney DH, Rollag MD. Blue Light from Light-Emitting Diodes Elicits a Dose-Dependent Suppression of Melatonin in Humans. J. Appl. Physiol. 2011;110:619–626.
Takasu NN, Hashimoto S, Yamanaka Y, Tanahashi Y, Yamazaki A, Honma S, Honma K. Repeated Exposures to Daytime Bright Light Increase Nocturnal Melatonin Rise and Maintain Circadian Phase in Young Subjects under Fixed Sleep Schedule. Am. J. Physiol.-Regul. Integr. Comp. Physiol. 2006;291:R1799–R1807.
Dauchy RT, Dauchy EM, Hanifin JP, Gauthreaux SL, Mao L, Belancio VP, Ooms TG, Dupepe LM, Jablonski MR, Warfield B. Effects of Spectral Transmittance through Standard Laboratory Cages on Circadian Metabolism and Physiology in Nude Rats. J. Am. Assoc. Lab. Anim. Sci. 2013;52:146–156.